Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis

doi:10.1016/0140-6736(90)92571-X

The Lancet

Volume 336, Issue 8723, 3 November 1990, Pages 1094-1096

https://doi.org/10.1016/0140-6736(90)92571-X Get rights and content

Abstract

Ribotyping, a method of strain identification based on analysis of bacterial genomic restriction fragment length polymorphisms, was used to investigate the acquisition of Pseudomonas cepacia by a patient with cystic fibrosis. Analysis of isolates recovered from the index patient and his contacts showed person-to-person transmission of this opportunist organism. This documentation of the transmission of P cepacia from one cystic fibrosis patient to another suggests that measures to limit the acquisition of the pathogen by patients with cystic fibrosis may be worth while.

References (25)

A. Isles et al.
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem
J Pediatr
(1984)
Oc Tablan et al.
Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis: risk factors and outcomes
Chest
(1987)
Oc Tablan et al.
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome
J Pediatr
(1985)
A. Prince
Antibiotic resistance of Pseudomonas species.
J Pediatr
(1986)
RC. Stern
The primary care physician and the patient with cystic fibrosis
J Pediatr
(1989)
Ka Hardy et al.
Pseudomonas cepacia in the hospital setting: lack of transmission between cystic fibrosis patients
J Pediatr
(1986)
Jj LiPuma et al.
Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers
J Pediatr
(1988)
Bj Rosenstein et al.
Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis.
Johns Hopkins Med J
(1980)
OC. Tablan
National Surveillance of P cepacia Study Group, Cystic Fibrosis Foundation. National surveillance of Pseudomonas cepacia colonization of cystic fibrosis patients—an update
Pediatr Pulmonol
(1989)
Mj Thomassen et al.
Pseudomonas cepacia colonization among patients with cystic fibrosis: a new opportunist
Am Rev Respir Dis
(1985)

R. Gold et al.

Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas capacia.

J Antimicrob Chemother

(1983)

A. Prince

Pseudomonas cepacia in cystic fibrosis patients

Am Rev Respir Dis

(1986)

Cited by (262)

Opportunistic premise plumbing pathogens (OPPPs) in the built-environment
2021, Viruses, Bacteria and Fungi in the Built Environment: Designing Healthy Indoor Environments
Opportunistic premise plumbing pathogens (OPPPs) are environmental, waterborne opportunistic pathogens that are present in drinking water. They include Legionella pneumophila, Pseudomonas aeruginosa, Burkholderia cepacia, Mycobacterium avium complex (MAC), Mycobacterium abscessus complex (MAA), Stenotrophomonas maltophilia, Acinetobacter baumannii, Sphingomonas paucimobilis, Segniliparus spp., Methylobacterium spp., Cupriavidus spp., and the free-living amoebae (e.g., Acanthamoeba and Vermamoeba spp.). As OPPPs are in drinking water, humans continually come in contact with them and become infected. The OPPPs are adapted to premise plumbing; the plumbing in homes, apartments, and hospitals. The presence of OPPP in plumbing is due to a number of shared characteristics, including disinfectant resistance, growth at low organic content, adherence to pipe surfaces, biofilm formation, growth at low oxygen content, and high temperature- and desiccation-tolerance. The presence of OPPPs in drinking water systems challenge current methods for monitoring and ensuring safe drinking water.
Infectious Complications in Special Hosts
2018, Principles and Practice of Pediatric Infectious Diseases
A case report of the treatment of obsessive compulsive disorder in a patient with Cystic Fibrosis: Potential protective role of contamination fears
2017, Journal of Obsessive-Compulsive and Related Disorders
Cystic fibrosis cloud database: An information system for storage and management of clinical and microbiological data of cystic fibrosis patients
2016, Revista Argentina de Microbiologia
El manejo clínico y epidemiológico de los pacientes con fibrosis quística (FQ) con exacerbaciones pulmonares agudas o infecciones pulmonares crónicas demanda una actualización permanente de procedimientos médicos y microbiológicos, estos se asocian con la constante evolución de los agentes patógenos durante la colonización de su hospedador. Para poder monitorear la dinámica de estos procesos es fundamental disponer de sistemas expertos que permitan almacenar, extraer y utilizar la información generada a partir de estudios realizados sobre el paciente y los microorganismos aislados de aquel. En este trabajo hemos diseñado y desarrollado una base de datos on-line basada en un sistema informático que permite el almacenamiento, el manejo y la visualización de la información proveniente de estudios clínicos y de análisis microbiológicos de bacterias obtenidas del tracto respiratorio del paciente con FQ. Este sistema informático fue designado como Cystic Fibrosis Cloud database (CFC database) y está disponible en el sitio http://servoy.infocomsa.com/cfc_database. Está compuesto por una base de datos principal y una interfaz on-line, la cual emplea la arquitectura de productos Servoy basada en tecnología Java. Si bien el sistema CFC database puede ser implementado como un programa local de uso privado en los centros de asistencia a pacientes con FQ, admite también la posibilidad de ser empleado, actualizado y compartido por diferentes usuarios, quienes pueden acceder a la información almacenada de manera ordenada, práctica y segura. La implementación del CFC database podría tener una gran impacto en la monitorización de las infecciones respiratorias, la prevención de exacerbaciones, la detección de organismos emergentes y la adecuación de las estrategias de control de infecciones pulmonares en pacientes con FQ.
The epidemiological and clinical management of cystic fibrosis (CF) patients suffering from acute pulmonary exacerbations or chronic lung infections demands continuous updating of medical and microbiological processes associated with the constant evolution of pathogens during host colonization. In order to monitor the dynamics of these processes, it is essential to have expert systems capable of storing and subsequently extracting the information generated from different studies of the patients and microorganisms isolated from them. In this work we have designed and developed an on-line database based on an information system that allows to store, manage and visualize data from clinical studies and microbiological analysis of bacteria obtained from the respiratory tract of patients suffering from cystic fibrosis. The information system, named Cystic Fibrosis Cloud database is available on the http://servoy.infocomsa.com/cfc_database site and is composed of a main database and a web-based interface, which uses Servoy's product architecture based on Java technology. Although the CFC database system can be implemented as a local program for private use in CF centers, it can also be used, updated and shared by different users who can access the stored information in a systematic, practical and safe manner. The implementation of the CFC database could have a significant impact on the monitoring of respiratory infections, the prevention of exacerbations, the detection of emerging organisms, and the adequacy of control strategies for lung infections in CF patients.
Microbial Epidemiology of the Cystic Fibrosis Airways: Past, Present, and Future
2023, Seminars in Respiratory and Critical Care Medicine
Opportunistic premise plumbing pathogens
2023, Opportunistic Premise Plumbing Pathogens

View all citing articles on Scopus

View full text

Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis

Abstract

J Pediatr

Chest

J Pediatr

J Pediatr

J Pediatr

J Pediatr

J Pediatr

Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis.

Johns Hopkins Med J

National Surveillance of P cepacia Study Group, Cystic Fibrosis Foundation. National surveillance of Pseudomonas cepacia colonization of cystic fibrosis patients—an update

Pediatr Pulmonol

Pseudomonas cepacia colonization among patients with cystic fibrosis: a new opportunist

Am Rev Respir Dis

Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas capacia.

J Antimicrob Chemother

Pseudomonas cepacia in cystic fibrosis patients

Am Rev Respir Dis